Market Place
Sourcing Support
All News #Library
Biotech
Bluerock Therapeutics Reveals Positive 36-Month Phase I Trial
07 Oct 2025 //
BUSINESSWIRE
Bayer-owned BlueRock lays off 50 employees, shuts Cambridge labs
26 Jun 2025 //
FIERCE BIOTECH
Bayer and BlueRock`s Journey in Cell Therapy Future
02 Jun 2025 //
FIERCE BIOTECH
BlueRock Therapeutics` Cell Therapy Shows Positive 24-Month Data
27 Sep 2024 //
BUSINESSWIRE
BlueRock Gets FDA RMAT For Parkinson`s Cell Therapy Bemdaneprocel
31 May 2024 //
INDINPHARMAPOST
BlueRock exercises option to license iPSC cell therapy candidate OpCT-001
23 Jan 2024 //
PR NEWSWIRE
BlueRock’s Phase I study with bemdaneprocel in patients meets primary endpoint
02 Oct 2023 //
PRESS RELEASE
BlueRock`s Ph I study with bemdaneprocel with PD meets primary endpoint
28 Aug 2023 //
PR NEWSWIRE
Bayer: Phase I trial results from Parkinson`s cell therapy positive
28 Jun 2023 //
REUTERS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.